Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07556406
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Optical coherence tomography — DIAGNOSTIC_TESTHigh-resolution imaging method used to evaluate the structure of the retina
- Microperimetry — DIAGNOSTIC_TESTA functional test that maps retinal sensitivity by measuring how well you can detect lights in different areas of your vision.
Study Details
This study is being conducted to assess two imaging methods-central microperimetry and radial OCT (Optical Coherence Tomography)-in patients with Geographic Atrophy (GA) or those who are at risk of developing this condition. The study team is trying to determine whether these methods can provide more accurate measurements of GA progression toward the foveal center, the central part of the retina responsible for your sharpest, most detailed vision.
Key Dates
- Start date
- Jun 11, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 11, 2027
- Completion
- Jun 11, 2027
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Non-central geographic atrophy not being treatedPatients with age-related macular degeneration who have geographic atrophy that does not involve the fovea.
- Arm: Intermediate age-related macular degenerationPatients with intermediate age-related macular degeneration
- Arm: Non-central geographic atrophy currently being treatedPatients with non-central geographic atrophy from age-related macular degeneration who are currently receiving treatment for this condition.
- Arm: Non-central geographic atrophy initiating treatmentPatients with non-central geographic atrophy from age-related macular degeneration who will be starting to receive treatment for this condition.
Primary Outcome Measure
Geographic atrophy progression rate [ Time Frame: 1 year ]
Central Contacts
- Jay M Stewart, MD(628) 206-3123
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Jay M Stewart, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationPHASE1 · Recruiting · Astellas Institute for Regenerative Medicine · Phoenix, Arizona
- Village-Integrated Eye Worker Trial IIRecruiting · University of California, San Francisco · San Francisco, California
- Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDRecruiting · VisionCare, Inc. · Loma Linda, California
- A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251PHASE2 · Recruiting · Genentech, Inc. · Beverly Hills, California